These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16260277)

  • 1. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR; Susani M; Wrba F; Haitel A
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A; Kaygusuz G; Ekinci C
    Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary liver carcinoma arising in people younger than 30 years.
    Klein WM; Molmenti EP; Colombani PM; Grover DS; Schwarz KB; Boitnott J; Torbenson MS
    Am J Clin Pathol; 2005 Oct; 124(4):512-8. PubMed ID: 16146811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.